Key facts
- Granger Management is a family office based in New York, New York with 4 tracked portfolio companies.
- Notable positions include Route, Geneoscopy, Lucem Health, Nucleus RadioPharma.
- Granger Management reports $24.7M in regulatory assets under management across 8 private funds, per its SEC Form ADV (2026-03).
Registered with the SEC
Form ADV · 2026-03 · CRD 168096- Regulatory AUM
- $24.7M
- Private fund assets
- $829.2M
- Private funds
- 8 · 8 private equity
- Staff
- 12
- Registered office
- NEW YORK, NY
- SEC status
- Approved
Reports custody of client assets.
Source: SEC Investment Adviser Public Disclosure, Form ADV (registered as GRANGER MANAGEMENT LLC).
Free account
See the whole book
- ·Watchlist + alerts for Granger Management's activity
Create free account
No card required
Portfolio, priced
4 companies · by our current valuations| Company | Industry | Valuation | First invested | Role |
|---|---|---|---|---|
| Route | Logistics | $1.4B | — | |
| Geneoscopy | — | $440.0M | — | |
| Lucem Health | — | $18.7M | — | |
| Nucleus RadioPharma | — | — | — |
Frequently asked
- What companies does Granger Management invest in?
- Granger Management has 4 recorded portfolio companies, including Route, Geneoscopy, Lucem Health, Nucleus RadioPharma.